Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Jugular Veins | 2 | 2017 | 73 | 1.040 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2017 | 100 | 1.020 |
Why?
|
| Upper Extremity | 2 | 2017 | 65 | 1.000 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2017 | 76 | 0.990 |
Why?
|
| Endovascular Procedures | 4 | 2021 | 334 | 0.970 |
Why?
|
| Renal Dialysis | 2 | 2017 | 364 | 0.840 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2017 | 239 | 0.560 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 258 | 0.400 |
Why?
|
| Stents | 7 | 2021 | 422 | 0.330 |
Why?
|
| Vascular Patency | 5 | 2017 | 127 | 0.310 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2017 | 100 | 0.260 |
Why?
|
| Venous Thrombosis | 2 | 2021 | 258 | 0.250 |
Why?
|
| Femoral Artery | 3 | 2011 | 91 | 0.210 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2011 | 111 | 0.210 |
Why?
|
| Biliary Tract Neoplasms | 2 | 2012 | 37 | 0.180 |
Why?
|
| Phlebography | 3 | 2017 | 68 | 0.180 |
Why?
|
| Portal Vein | 1 | 2021 | 122 | 0.170 |
Why?
|
| Bile Duct Neoplasms | 1 | 2021 | 91 | 0.170 |
Why?
|
| Embolization, Therapeutic | 3 | 2014 | 279 | 0.160 |
Why?
|
| Arm | 1 | 2000 | 100 | 0.160 |
Why?
|
| Catheterization, Peripheral | 1 | 2000 | 64 | 0.160 |
Why?
|
| Catheterization, Central Venous | 1 | 2000 | 120 | 0.150 |
Why?
|
| Treatment Outcome | 6 | 2021 | 9228 | 0.150 |
Why?
|
| Carcinoma | 2 | 2012 | 444 | 0.140 |
Why?
|
| Ampulla of Vater | 2 | 2014 | 25 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2017 | 41 | 0.130 |
Why?
|
| Femoral Vein | 1 | 2016 | 43 | 0.120 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 790 | 0.120 |
Why?
|
| Vena Cava Filters | 1 | 2016 | 90 | 0.120 |
Why?
|
| Vena Cava, Inferior | 1 | 2016 | 142 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 725 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 135 | 0.110 |
Why?
|
| Device Removal | 1 | 2016 | 169 | 0.110 |
Why?
|
| Postoperative Hemorrhage | 1 | 2014 | 50 | 0.110 |
Why?
|
| Hepatic Artery | 1 | 2014 | 84 | 0.100 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2014 | 92 | 0.100 |
Why?
|
| Patient Selection | 1 | 2017 | 708 | 0.100 |
Why?
|
| Aged | 8 | 2021 | 20927 | 0.090 |
Why?
|
| Middle Aged | 8 | 2021 | 28299 | 0.080 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2011 | 248 | 0.070 |
Why?
|
| Humans | 14 | 2021 | 95992 | 0.070 |
Why?
|
| Female | 10 | 2021 | 49980 | 0.070 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2008 | 28 | 0.070 |
Why?
|
| Pregnancy, Ectopic | 1 | 2008 | 37 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 1191 | 0.070 |
Why?
|
| Cicatrix | 1 | 2008 | 77 | 0.070 |
Why?
|
| Methotrexate | 1 | 2008 | 232 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 7224 | 0.060 |
Why?
|
| Popliteal Artery | 1 | 2007 | 30 | 0.060 |
Why?
|
| Iliac Vein | 1 | 2006 | 32 | 0.060 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2007 | 108 | 0.060 |
Why?
|
| Angioplasty | 1 | 2006 | 69 | 0.060 |
Why?
|
| Cesarean Section | 1 | 2008 | 158 | 0.060 |
Why?
|
| Angioplasty, Balloon | 1 | 2007 | 98 | 0.060 |
Why?
|
| Wounds, Penetrating | 1 | 2006 | 56 | 0.060 |
Why?
|
| Cysts | 1 | 2007 | 104 | 0.060 |
Why?
|
| Uterus | 1 | 2008 | 228 | 0.060 |
Why?
|
| Blood Loss, Surgical | 1 | 2006 | 133 | 0.060 |
Why?
|
| Male | 7 | 2021 | 45792 | 0.060 |
Why?
|
| Diskectomy | 1 | 2006 | 95 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2007 | 249 | 0.060 |
Why?
|
| Prosthesis Design | 2 | 2016 | 311 | 0.050 |
Why?
|
| Spinal Fusion | 1 | 2006 | 348 | 0.040 |
Why?
|
| Endoscopy, Digestive System | 2 | 2012 | 72 | 0.040 |
Why?
|
| Mesenteric Veins | 1 | 2021 | 36 | 0.040 |
Why?
|
| Cholangiocarcinoma | 1 | 2021 | 80 | 0.040 |
Why?
|
| Radiography, Interventional | 1 | 2000 | 155 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2011 | 1982 | 0.040 |
Why?
|
| Movement | 1 | 2000 | 324 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2011 | 180 | 0.030 |
Why?
|
| Angiography | 2 | 2008 | 209 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 587 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 1618 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2014 | 295 | 0.020 |
Why?
|
| Jaundice, Obstructive | 1 | 2012 | 11 | 0.020 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2012 | 12 | 0.020 |
Why?
|
| Gallbladder | 1 | 2012 | 33 | 0.020 |
Why?
|
| Electroporation | 1 | 2012 | 59 | 0.020 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2012 | 68 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2012 | 121 | 0.020 |
Why?
|
| Radiology, Interventional | 1 | 2012 | 66 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2000 | 4690 | 0.020 |
Why?
|
| Ablation Techniques | 1 | 2012 | 43 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2012 | 126 | 0.020 |
Why?
|
| Ankle Brachial Index | 1 | 2011 | 28 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2011 | 26 | 0.020 |
Why?
|
| Photochemotherapy | 1 | 2012 | 101 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2011 | 42 | 0.020 |
Why?
|
| Drainage | 1 | 2012 | 172 | 0.020 |
Why?
|
| Brachytherapy | 1 | 2012 | 127 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 207 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 353 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 365 | 0.020 |
Why?
|
| Warfarin | 1 | 2011 | 107 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2012 | 234 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2012 | 325 | 0.020 |
Why?
|
| Aspirin | 1 | 2011 | 169 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2012 | 419 | 0.020 |
Why?
|
| Illinois | 1 | 2011 | 530 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 1741 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 712 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 476 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2008 | 66 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 1079 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2011 | 465 | 0.020 |
Why?
|
| Adolescent | 1 | 2000 | 9878 | 0.020 |
Why?
|
| Endosonography | 1 | 2008 | 101 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 10307 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2012 | 591 | 0.020 |
Why?
|
| Brachial Artery | 1 | 2007 | 36 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 2007 | 75 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2008 | 155 | 0.020 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2007 | 62 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2007 | 91 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 2042 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 3993 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2007 | 94 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2007 | 201 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2008 | 245 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2007 | 99 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 1533 | 0.010 |
Why?
|
| Adult | 2 | 2008 | 28636 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2007 | 600 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2008 | 747 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2012 | 1201 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 859 | 0.010 |
Why?
|
| Comorbidity | 1 | 2008 | 1017 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 436 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2006 | 363 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 5593 | 0.010 |
Why?
|
| Hypertension | 1 | 2007 | 775 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 3922 | 0.010 |
Why?
|
| Pregnancy | 1 | 2008 | 3239 | 0.010 |
Why?
|
| Mutation | 1 | 2012 | 4374 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 771 | 0.010 |
Why?
|
| Heart Failure | 1 | 2007 | 1438 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 2777 | 0.010 |
Why?
|